Hydroxyapatite coating of cellulose sponge does not improve its osteogenic potency in rat bone
Source abstract
Abstract
Regenerated cellulose sponges were coated biomimetically with hydroxyapatite to increase their osteogenic properties. Induction of apatite precipitation was carried out with bioactive glass in simulated body fluid (SBF) for 24 h and the final coating was carried out in 1.5 x concentrated SBF for 14 days. Biomimetically mineralized and non-mineralized sponges were then implanted into standard size femoral cortical defects of rats, and the invasion of bone into the implant was followed up to one year. The apatite coating did not improve the osteoconductive property of cellulose in this rat cortical defect model. In fact, it generated a strong and highly cellular inflammatory reaction and less osteoid tissue. The biomimetic implants contained more immunodetectable TGFbeta1 (a strong stimulator of fibroblast activity) than untreated implants, and also bound more TGFbeta1 in vitro, which could, at least in part, explain the fibrotic invasion of biomimetically mineralized sponges.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Facial Trauma and Fracture Management
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (35)
Show source-provided references
1. Is cellulose sponge degradable or stable as implantation material? An in vivo subcutaneous study in the rat10.1016/S0142-9612(99)00094-0 ↗
2. Stimulation of granulation tissue growth in burns
3. Local hyperalimentation of open wounds10.1002/bjs.1800630603 ↗
4. Bone formation in an implant is a mileu-dependent phenomenon. An experimental study with cellulose sponge in rat
5. Biocompatibility of cellulose sponge with bone10.1159/000008609 ↗
6. Apatite formation on ceramics, metals and polymers induced by a CaO SiO2 based glass in a simulated body fluid10.1016/B978-0-7506-0269-3.50020-7 ↗
7. Repair of orbital floor fractures with bioactive glass implants10.1053/joms.2001.27524 ↗
8. Third-generation biomedical materials10.1126/science.1067404 ↗
9. Characterization of Ca/P layer produced on porous synthetic organic matrix by biomimetic method
10. Analysis of in vitro reaction layers formed on Bioglass using thin-film X-ray diffraction and ATR-FTIR microspectroscopy10.1002/(SICI)1097-4636(199807)41:1<162::AID-JBM19>3.0.CO;2-P ↗
11. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction10.1016/0003-2697(87)90021-2 ↗
12. Specific hybridization probes for mouse type I, II, III and IX collagen mRNAs10.1016/0167-4781(91)90014-D ↗
13. Cloning of cDNA for rat pro alpha 1(III) collagen mRNA. Different expression patterns of type I and type III collagen and fibronectin genes in experimental granulation tissue
14. Murine fibromodulin: cDNA and genomic structure, and age-related expression and distribution in the knee joint10.1042/bj3550577 ↗
15. Expression of extracellular matrix genes, transforming growth factor (TGF)-β1 and ras in tibial fracture healing of lathyritic rats10.1016/S8756-3282(00)00359-8 ↗
16. Osteoconductive coatings for total hip arthroplasty10.1097/00003086-200202000-00007 ↗
17. Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium
18. The effect of pH on the structural evolution of accelerated biomimetic apatite10.1016/j.biomaterials.2003.12.037 ↗
19. The effect of biomimetic apatite structure on osteoblast viability, proliferation, and gene expression10.1016/j.biomaterials.2004.02.030 ↗
20. Bone bonding ability of an apatite-coated polymer produced using a biomimetic method: a mechanical and histological study in vivo10.1002/(SICI)1097-4636(199608)31:4<487::AID-JBM8>3.0.CO;2-H ↗
21. Mineralization of regenerated cellulose hydrogels10.1023/A:1013960601330 ↗
22. Inflammatory cytokine production by immunological and foreign body multinucleated giant cells10.1046/j.1365-2567.2000.00025.x ↗
23. Increased interleukin-8 (IL-8) expression is related to aseptic loosening of total hip replacement10.1007/s004020050475 ↗
24. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha10.1074/jbc.M106339200 ↗
25. Tumor necrosis factor-α: molecular and cellular mechanisms in skeletal pathology
26. TGF-beta and fibrosis10.1016/S1286-4579(99)00250-6 ↗
27. The effect of transforming growth factor-beta1, released from a bioabsorbable self-reinforced polylactide pin, on a bone defect10.1016/S0142-9612(02)00105-9 ↗
28. Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts10.1042/bj2710827 ↗
29. Differential cytokine regulation of type I and type VII collagen gene expression in cultured human dermal fibroblasts10.1016/S0021-9258(17)42303-9 ↗
30. Alteration of proteoglycan synthesis in human lung fibroblasts induced by interleukin-1beta and tumor necrosis factor-alpha10.1002/(SICI)1097-4644(20000501)77:2<298::AID-JCB12>3.0.CO;2-D ↗
31. Tumour necrosis factor-alpha interacts with biglycan and decorin10.1016/S0014-5793(02)03439-7 ↗
32. Gene expression during bone repair10.1097/00003086-199304000-00043 ↗
33. Genetic expression of extracellular matrix proteins correlates with histologic changes during fracture repair10.1002/jbmr.5650070907 ↗
34. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-beta10.1074/jbc.M111718200 ↗
35. Holmbom J, Södergård A, Ekholm E, Märtson M, Kuusilehto A, Saukko P, et al. Long-term evaluation of porous poly(ε-caprolactone-co-l-lactide) as a bone filling material. J Biomed Mater Res, in press.